• Email Preferences
    • Logout
    loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
    • Email Preferences
    • Logout
    loading
    Member
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 67
  3. 68
  4. 69
  5. 70
  6. 71
  7. …
  • Study: AstraZeneca Vaccine Efficacy Against South African Variant

    18 March, 2021

    No protection against mild to moderate disease…

    COVID-19, General Articles

  • European and UK regulators confirm that people should continue to receive the COVID-19 vaccine AstraZeneca

    18 March, 2021

    Safety of the vaccine will continue to be monitored...

    COVID-19

  • Over 65s are at a higher risk of COVID-19 reinfection, study

    Denmark // 18 March, 2021

    A study published in the Lancet...

    COVID-19

  • 75% of over 70s have COVID-19 antibodies, study

    United Kingdom // 18 March, 2021

    Between the ages of 70 and 84 had antibodies against COVID-19...

    COVID-19

  • ECDC issues publications on contact budget, possibility of self tests

    18 March, 2021

    Publications on contact budget and possibility of self tests

    COVID-19

  • Vaccine Update - Over a million vaccines administered

    Greece // 17 March, 2021

    Greece’s Ministry of Health held a press conference on March 16...

    COVID-19

  • Medicago and GSK commence phase 3 trial of COVID-19 vaccine candidate

    Canada // 17 March, 2021

    Medicago start phase 3 trials...

    COVID-19

  • Vaccine update - programme launched

    Djibouti // 17 March, 2021

    The Ministry of Health announced the start of the vaccination programme...

    COVID-19

  • Detections of P.3 variant strain outside the Philippines

    United Kingdom // Philippines // 17 March, 2021

    Variant P,3 in the United Kingdom...

    COVID-19

  • Chinese Embassy begins vaccination

    Egypt // 17 March, 2021

    Sinopharm available to Chinese nationals in Egypt

    COVID-19

  • Moderna begins vaccine testing in childen

    United States // Canada // 17 March, 2021

    Moderna announced yesterday that they have begun administering their COVID-19 vaccine, mRNA-1273, to the first participants in the Phase 2/3 study called the KidCOVE.

    COVID-19

  • Moderna to test its vaccine in children under 12 years old

    16 March, 2021

    The first participants in its Phase2/3 study have received their first dose...

    COVID-19

  • New Visa Information for Applicants with COVID-19 Vaccines produced in China

    China // 16 March, 2021

    Eligable visa applicants need vaccine produced in China...

    COVID-19

  • New variant of SARS-CoV-2 identified

    France // 16 March, 2021

    A new strain has been identified that may evade PCR tests.

    COVID-19

  • Vaccine update - COVID-19 vaccines arrive via COVAX

    Somalia // 15 March, 2021

    At least 300,000 doses...

    COVID-19

  • Moderna’s next generation COVID-19 vaccine mRNA-1283, participants in Phase 1 received doses

    15 March, 2021

    Phase 1 trials of Moderna's mRNA-1283 vaccine start...

    COVID-19

  • Higher death rate in B.1.1.7 SARS-CoV-2 variant, study

    15 March, 2021

    Study suggests B.1.1.7 variant causes more severe illness...

    COVID-19

  • Coronavirus passports - British Airways plan

    United Kingdom // Denmark // 14 March, 2021

    Countries consider issuing "vaccine passports" ...

    COVID-19

  • Vaccine update - use of single batch of AstraZeneca suspended

    Romania // 14 March, 2021

    Use of batch ABV2856 has been suspended...

    COVID-19

  • ECDC issues guidance for COVID-19 quarantine and testing of travellers

    14 March, 2021

    The guidance summarises the current scientific evidence to support decision-making with regard to quarantine and testing of travellers....

    COVID-19

  1. …
  2. 67
  3. 68
  4. 69
  5. 70
  6. 71
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS